knowledge -WSS

knowledge

author：entertainment 2025-08-11 08:00:41 - browse：13531

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Report: NIH

hotspot

WSS

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Startling documents reveal new facets of Sacklers' opioid empire

Dark money group runs ads on China biotech bill

Startling documents reveal new facets of Sacklers' opioid empire

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Antibiotic resistance nearly killed me, so I'm raising awareness of it

explore

knowledge

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Average age of first period drops to 11.9 years, study shows

Peter Hotez and the public health issue of online harassment

Heat waves linked to early deliveries, preterm births in new study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Childbirth

Medical leaders decry Supreme Court decision on affirmative action

Focused ultrasound for uterine fibroids: an uphill battle

Activists slam private health insurers over coverage restrictions

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

leisure time

Biohaven protein

Prosthetic arm enables patients to feel the objects they grip

Health insurers say they are turning to AI to cut costs, improve care

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

UnitedHealth wins $3.3 billion takeover of Amedisys

Illumina to lay off 10% of research and development team

hotspot

Wikipedia

entertainment

Wikipedia